Trial NCT00610792

View at ClinicalTrials.gov 
Org. Study IDs: 26866138-OVC-2001
Secondary IDs: S043VELC02

Last trial update was posted on 2009-07-14

MeSH Interventions

Bortezomib Doxorubicin Liposomal doxorubicin

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID